Page 8 - Hepatology Society News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hepatology society. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hepatology Society Today - Breaking & Trending Today

Higher intensity exercise associated with greater decrease in nonalcoholic fatty liver disease risk

1. This analysis of a population-based cohort found that those who engaged in high and moderate decreasing amounts of vigorous physical activity (VPA) over twenty-five years decreased their relative risk of developing nonalcoholic fatty liver disease (NAFLD) by 41%, emphasizing that vigorous (as opposed to moderate) physical activity in early adulthood provided the most benefit. ....

Artery Risk Development In Young Adults , Rating Level , Coronary Artery Risk Development , Young Adults , Chronic Disease ,

Man Searches Crowded Bus For Least-Wounded Person To Sit Next To

CHICAGO Scanning the public transit vehicle for even one superficially healthy passenger, local man Will Ossers reportedly searched a crowded bus Friday for the least-wounded person to sit next to. “Hmm, would I rather sit next to someone with skin lesions or with a bloody gash on their forehead?” Ossers said as he… ....

United States , Will Ossers , Will Ossers , Body Fluids , He Onion ,

Institute of Gastroenterology and Hepatology partners with AI endoscopy startup

The Institute of Gastroenterology and Hepatology signed a joint research agreement with Tokyo-based medtech start-up AI Medical Service to develop diagnostic en ....

Republic Of , Institute Of Gastroenterology , Tai Medical Service , Artificial Intelligence , Start Up ,

Camrelizumab plus rivoceranib superior to sorafenib for treatment of unresectable hepatocellular carcinoma

1. Patients in the camrelizumab-rivoceranib group reported significantly greater progression-free survival than the sorafenib group. 2. Treatment-related deaths were comparable among patients in either group. Evidence Rating Level: 1 (Excellent) Study Rundown: Hepatocellular carcinoma comprises a predominant portion of primary liver malignancies. Immunotherapy combined with anti-angiogenic treatment has shown promise in various advanced solid tumors, ....

Rating Level , Unresectable Hepatocellular , Between Jun , Hepatocellular Carcinoma , Hepatocellular Carcinoma Hcc , Liver Cancer , Chronic Disease ,